Sandu Pharma Approves Final Dividend of ₹1 per Share for FY 2025-26

The Board of Directors of Sandu Pharmaceuticals Limited approved a final dividend of ₹1 per equity share for the financial year 2025-26, as of March 31, 2026. The dividend is subject to the approval of shareholders at the upcoming Annual General Meeting (AGM). The date of the AGM, the record date for determining eligibility for the dividend, and the dividend payout date will be announced later.